BMY

FDA Eases Rules For Bristol Myers' Cell Therapies For Blood Cancers

06/27 11:34 am

2 Beaten-Down Stocks to Avoid

06/27 08:15 am

Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight

06/24 01:00 pm

ICPO Foundation ist Co-Founder der RLT Angels Association mit dem Ziel, den Zugang zur Radiotheranostik für eine Million PatientInnen auszubauen

06/21 06:20 am

ICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients

06/21 06:20 am

Editas Medicine Is Great. Here's Why You Shouldn't Buy It.

06/17 10:07 am

2 Beaten-Down Dividend Stocks to Buy Right Now

06/16 04:25 am

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties

06/10 05:55 pm

Rheumatoid Arthritis Global Market Research Report 2025-2035: TNF Inhibitors, IL-6 Inhibitors, and JAK Inhibitors at the Forefront of Developing Biologic Therapies

06/10 04:53 am

Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight

06/05 01:00 pm

Epigenetics Market Anticipated to Achieve 11.8% CAGR

06/03 01:31 pm

Bristol Myers Inks $11 Billion Licensing Pact With BioNTech For Bispecific Cancer Drug

06/02 10:14 am

Bispecific Antibody Drug Conjugates Clinical Trials Bispecific ADC Market Size Insight

05/29 01:16 pm

Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors

05/27 09:00 am

GlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases

05/27 07:00 am

Tubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic

05/20 05:00 am

Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight

05/12 01:00 pm

U.S. Small Business Association Awards Renaissance Global Services Two Prestigious Honors

05/09 07:00 am

FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight

05/06 03:21 pm

FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months

05/02 03:37 pm

This High-Yield Pharma Stock Looks Like an Incredible Bargain

04/30 06:45 am

Analysis of Cancer Immunotherapy Technologies and Global Markets to 2029 - Merck, Roche, Bristol-Myers Squibb Company, Johnson & Johnson Services, and AstraZeneca Dominate

04/30 04:56 am

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off

04/26 06:05 pm

Bristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact

04/24 11:55 am

Thermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll

04/23 04:49 pm

Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight-Loss Pill?

04/15 07:39 am

These Large-Cap Stocks With China And EU Exposure Got Crushed In The One Of The Most Volatile Trading Week (Apr 7-Apr 11): Are These In Your Portfolio?

04/13 11:33 am

Specialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights

04/10 01:58 pm

Biopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline

04/10 05:59 am

Is Vertex Pharmaceuticals Stock a Buy?

04/08 09:45 am

Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide

04/08 04:48 am

MPYS Protein Stimulants Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 10+ Leading Players Wheeling the Therapeutics Landscape

04/07 01:00 pm

Is Bristol Myers Squibb's High-Yielding Dividend Safe?

04/02 05:40 am

Tumor-infiltrating Lymphocyte (TIL) Therapies Global Market Report 2025: 75+ Therapies are Under Development and 100+ Clinical Trials are Underway Globally

04/01 02:44 pm

Beat the S&P 500 With This Cash-Gushing Dividend Stock

04/01 08:00 am

Why Pfizer Is My Largest Healthcare Position

03/27 06:45 am

Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed

03/21 12:31 pm

5 Reasons the Schwab U.S. Dividend Equity ETF Is a Long-Term Buy for 2030 and Beyond

03/17 07:45 am

Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 in Combination with Nivolumab in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma

03/17 07:00 am

3 Stocks to Buy Amid Market Correction Triggered by Trump's Trade War

03/14 07:40 am

Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal

03/11 10:17 am

Bristol Myers Unveils Positive Phase 3 Results for Sotyktu in Psoriatic Arthritis

03/10 12:54 pm

Global Prostate Cancer Market to Reach USD 29.2 Billion by 2035, Driven by Aging Population and Awareness | Future Market Insights, Inc.

03/09 08:30 pm

Acetylcholine Receptor Antagonists Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

03/06 02:00 pm

Cancer Biomarkers Research Report 2024: Global Market Projected to Soar to USD 62.14 Billion by 2034, Driven by Technological Advancements and Increasing Demand for Early Detection

03/06 05:55 am

Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

03/03 02:00 pm

International Myeloma Foundation (IMF) Celebrates Myeloma Milestones for 2025 Myeloma Action Month

03/01 09:45 am

Got $200? 2 Healthcare Stocks to Buy and Hold Forever

02/26 05:32 am

TALTZ’s Rapid Market Ascent Reflects its Unparalleled Ability to Transform the Treatment Landscape for Autoimmune Diseases | DelveInsight

02/24 02:00 pm

Bristol Myers Colorectal Cancer Treatment Goes Under Priority FDA Review

02/24 01:24 pm